Similar Articles
361 Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis
362 Immunotherapy for hepatocellular carcinoma: Current status and future perspectives
363 Saccharomyces cerevisiae prevents postoperative recurrence of Crohn's disease modeled by ileocecal resection in HLA-B27 transgenic rats
364 Efficacy of dexamethasone and N-acetylcysteine combination in preventing post-embolization syndrome after transarterial chemoembolization in hepatocellular carcinoma
365 Treatment of recurrent hepatocellular carcinoma following liver resection, ablation or liver transplantation
366 Prognostic role of ring finger and WD repeat domain 3 and immune cell infiltration in hepatocellular carcinoma
367 Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion
368 Impact of body mass index in elderly patients treated with laparoscopic liver resection for hepatocellular carcinoma
369 Application of ablative therapy for intrahepatic recurrent hepatocellular carcinoma following hepatectomy
370 Perivascular epithelioid cell tumors of the liver misdiagnosed as hepatocellular carcinoma: Three case reports
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA